Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MEGHAN SRI KARUTURI and JENNIFER LITTON.
MEGHAN SRI KARUTURI
Connection Strength
0.469
JENNIFER LITTON
  1. A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2023 Jun; 199(3):457-469.
    View in: PubMed
    Score: 0.226
  2. Severe hyponatremia following cyclophosphamide infusion in breast cancer patients. Breast J. 2018 07; 24(4):691-692.
    View in: PubMed
    Score: 0.158
  3. A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer. Invest New Drugs. 2021 04; 39(2):509-515.
    View in: PubMed
    Score: 0.047
  4. Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation. J Cancer. 2017; 8(11):2004-2009.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.